SCHEMBL371534

SCHEMBL371534

O=CC(Cl)c1cc(Br)c(Br)s1

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28723184 1.00 GSK3B (0.35) GSK3B
SCHEMBL7070818 0.78 GSK3B (0.33) GSK3B
SCHEMBL7069585 0.69 CES2 (0.34) GSK3B
SCHEMBL7068555 0.69 DAO (0.36) GSK3B
SCHEMBL7069962 0.69 CES2 (0.34) GSK3B
SCHEMBL9967699 0.67 GSK3B (0.33) GSK3B
SCHEMBL947395 0.67
SCHEMBL2011610 0.67
SCHEMBL12615162 0.63 SLC6A2 (0.37)
SCHEMBL7073021 0.63 GSK3B (0.31) GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 111 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2925859-A1 MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS Takara Bio Europe AB (SE) 2015-10-07 EP claimed
EP-2797596-A1 PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR Zytoprotec GmbH (AT) 2014-11-05 EP claimed
WO-2014083132-A1 MATURATION OF HEPATOCYTE-LIKE CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS CELLECTIS SA (FR) 2014-06-05 WO claimed
WO-2013098140-A1 PERITONEAL DIALYSIS FLUID COMPRISING A GSK-3 INHIBITOR ZYTOPROTEC GMBH (AT) 2013-07-04 WO claimed
WO-2010108005-A2 NOVEL NEURAL PROGENITORS FROM PLURIPOTENT STEM CELLS, METHODS OF PRODUCING SAME AND USE TO PRODUCE NEURAL CELLS UNIVERSITY OF GEORGIA RESEARCH FOUNDATION (US) 2010-09-23 WO claimed
EP-2126045-A2 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2009-12-02 EP claimed
WO-2008094597-A2 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2008-08-07 WO claimed
EP-4578941-A2 COMBINED CHEMICAL AND GENETIC APPROACHES FOR GENERATION OF INDUCED PLURIPOTENT STEM CELLS The Scripps Research Institute (US) 2025-07-02 EP disclosed
US-20250136948-A1 INDUCTION OF PLURIPOTENT CELLS THE SCRIPPS RESEARCH INSTITUTE 2025-05-01 US disclosed
EP-4473093-A1 GENERATION OF BROWN ADIPOCYTES FROM HUMAN PLURIPOTENT STEM CELLS The Brigham and Women's Hospital, Inc. (US) 2024-12-11 EP disclosed
EP-4438734-A2 REPROGRAMMING OF CELLS TO A NEW FATE The Scripps Research Institute (US) 2024-10-02 EP disclosed
EP-3399026-B1 REPROGRAMMING OF CELLS TO A NEW FATE SCRIPPS RESEARCH INST (US) 2024-06-26 EP disclosed
WO-2024020405-A1 METHODS FOR DIFFERENTIATING AT2 CELLS LUNG BIOTECHNOLOGY PBC (US) 2024-01-25 WO disclosed
EP-2043633-A2 THIADIAZOLIDINONE DERIVATIVES University of Rochester (US) 2009-04-08 EP disclosed
EP-2001462-A2 INHIBITION OF MICROTUBULE PROTRUSION IN CANCER CELLS University of Maryland, Baltimore (US) 2008-12-17 EP disclosed
WO-2008094597-A2 EARLY MESODERM CELLS, A STABLE POPULATION OF MESENDODERM CELLS THAT HAS UTILITY FOR GENERATION OF ENDODERM AND MESODERM LINEAGES AND MULTIPOTENT MIGRATORY CELLS (MMC) UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) 2008-08-07 WO disclosed
WO-2008021210-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-02-21 WO disclosed
WO-2008011113-A2 THIADIAZOLIDINONE DERIVATIVES UNIVERSITY OF ROCHESTER (US) 2008-01-24 WO disclosed
WO-2007104011-A2 INHIBITION OF MICROTUBULE PROTRUSION IN CANCER CELLS UNIVERSITY OF MARYLAND, BALTIMORE (US) 2007-09-13 WO disclosed
WO-2003055479-A1 COMPOUNDS AND THEIR THERAPEUTIC USE RELATED TO THE PHOSPHORYLATING ACTIVITY OF THE ENZYME GSK-3 CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2003-07-10 WO disclosed